Single nucleotide polymorphisms in tobacco metabolism and DNA repair genes and prognosis in resected non-small-cell lung cancer

Journal of Surgical Research

Volumn 167, Issue 1, 2011, Pages

  Campayo, Marc ^a   Viñolas, Nuria ^a   Navarro, Alfons ^b   Carcereny, Enric ^c   Casas, Francesc ^a   Gel, Bernat ^d   Diaz, Tania ^b   Gimferrer, Josep Maria ^a   Marrades, Ramon M ^a   Ramirez, Jose ^a   Monzo, Mariano ^b  

^a HOSPITAL CLÍNIC   (Spain)

^b UNIVERSITY OF BARCELONA   (Spain)

^c HOSPITAL UNIVERSITARI GERMANS TRIAS I PUJOL   (Spain)

^d UNIVERSITAT POLITÈCNICA DE CATALUNYA   (Spain)

Author keywords

DNA repair; lung cancer; NSCLC; polymorphisms; SNP; tobacco metabolism

Indexed keywords

DNA;

ADULT; AGED; ARTICLE; CANCER PATIENT; CANCER SURGERY; DNA REPAIR; FEMALE; GENE FREQUENCY; GENOTYPE; HUMAN; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PRIORITY JOURNAL; PROGNOSIS; SINGLE NUCLEOTIDE POLYMORPHISM; SMOKING; TOBACCO; WILD TYPE;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, NON-SMALL-CELL LUNG; DNA REPAIR; DNA, NEOPLASM; FEMALE; HUMANS; KAPLAN-MEIER ESTIMATE; LUNG NEOPLASMS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; POLYMORPHISM, SINGLE NUCLEOTIDE; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL RATE; TOBACCO;

EID: 79953051976     PISSN: 00224804     EISSN: 10958673     Source Type: Journal    
DOI: 10.1016/j.jss.2011.01.007     Document Type: Article

References (45)

1. A. Jemal, R. Siegel, and E. Ward Cancer statistics, 2009 Ca Cancer J Clin 59 2009 225
2. M.D. Brundage, D. Davies, and W.J. Mackillop Prognostic factors in non-small-cell lung cancer: A decade of progress Chest 122 2002 1037
3. R. Arriagada, B. Bergman, and A. Dunant Cisplatin-based adjuvant chemotherapy in patients with completely resected non-small-cell lung cancer N Engl J Med 350 2004 351
4. PORT Meta-Analysis Trialist Group: Postoperative radiotherapy in non-small cell lung cancer: Systemic review and meta-analysis of individual patient data from nine randomized controlled trials Lancet 352 1998 257
5. S. Hecht Tobacco carcinogens, their biomarkers, and tobacco-induced cancer Nat Rev Cancer 3 2003 733
6. F.P. Guengerich Common and uncommon cytochrome P450 reactions related to metabolism and chemical toxicity Chem Res Toxicol 14 2001 611
7. S.S. Hecht Tobacco smoke carcinogens and lung cancer J Natl Cancer Inst 91 1999 1194
8. A. Sancar, La Lindsey-Boltz, and K. Unsal-Kamaz Molecular mechanisms of mammalian DNA repair and the DNA damage checkpoints Annu Rev Biochem 73 2004 39
9. E. Bauer, Z. Guo, and Y.F. Ueng Oxidation of benzo[a]pyrene by recombinant human cytochrome P450 enzymes Chem Res Toxicol 8 1995 136
10. A.E. Salinas, and M.G. Wong Glutathione S-transferases - A review Curr Med Chem 6 1999 279
11. J. Seidegrd, and G. Ekström The role of human glutathione transferases and epoxide hydrolases in the metabolism of xenobiotics Environ Health Perspect 105 1997 791
12. E. Sim, K. Walters, and S. Boukouvala Arylamine N-acetyltransferases: From structure to function Drug Metab Rev 40 2008 479
13. H. Bartsch, U. Nair, and A. Risch Genetic polymorphism of CYP genes, alone or in combination, as a risk modifier of tobacco-related cancers Cancer Epidemiol Biomarkers Prev 9 2000 3
14. D.W. Nebert, R.A. McKinnon, and A. Puga Human drug-metabolizing enzyme polymorphisms: Effects on risk of toxicity and cancer DNA Cell Biol 15 1996 273
15. A.K. Daly Pharmacogenetics of the major polymorphic metabolizing enzymes Fundam Clin Pharmacol 17 2003 27
16. S. Zienolddiny, D. Campa, and H. Lind A comprehensive analysis of phase I and phase II metabolism gene polymorphisms and risk of non-small-cell lung cancer in smokers Carcinogenesis 29 2008 1164
17. P. Gresner, J. Gromadzinska, and W. Wasowicz Polymorphism of selected enzymes involved in detoxification and biotransformation in relation to lung cancer Lung Cancer 57 2007 1
18. M.L. Cote, W. Chen, and D.W. Smith Meta- and pooled analysis of GSTP1 polymorphism and lung cancer: A HuGE-GSEC review Am J Epidemiol 169 2009 802
19. C. Kiyohara, K. Yoshimasu, and K. Takayama EPHX1 polymorphisms and the risk of lung cancer Epidemiology 17 2006 89
20. D.W. Hein Molecular genetics and function of NAT1 and NAT2: Role in aromatic amine metabolism and carcinogenesis Mutat Res 65 2002 506
21. M. Hashibe, P. Brennan, and R.C. Strange Meta- and pooled analyses of GSTM1, GSTT1, GSTP1, and CYP1A1 genotypes and risk of head and neck cancer Cancer Epidemiol Biomarkers Prev 12 2003 1509
22. R.D. Wood, M. Mitchell, and T. Lindahl Human DNA repair genes Mutation Res 577 2005 275
23. C. Kiyohara, and K. Yoshimasu Genetic polymorphisms in the nucleotide excision repair pathway and lung cancer risk: A meta-analysis Int J Med Sci 4 2007 59
24. R.J. Hung, P. Brennan, and F. Canzian Large-scale investigation of base excision repair genetic polymorphisms and lung cancer risk in a multicenter study J Natl Cancer Inst 97 2005 567
25. S. Zienolddiny, D. Campa, and H. Lind Polymorphisms of DNA repair genes and risk of non-small cell lung cancer Carcinogenesis 27 2006 560
26. Q. Wei, L. Cheng, and C.I. Amos Repair of tobacco carcinogen-induced DNA adducts and lung cancer risk: A molecular epidemiologic study J Natl Cancer Inst 92 2000 1764
27. H. Shen, M.R. Spitz, and Y. Qiao Smoking, DNA repair capacity and risk of nonsmall cell lung cancer Int J Cancer 107 2003 84
28. M.M. Gottesman, I. Pastan, and V. Ambudkar P-glycoprotein and multidrug resistance Curr Opin Genet Dev 6 1996 610
29. S. Zhou Structure, function and regulation of P-glycoprotein and its clinical relevance in drug disposition Xenobiotica 38 2008 802
30. S. Hoffmeyer, O. Burk, and O. von Richter Functional polymorphisms of the human multidrug resistance gene: Multiple sequence variations and correlation of one allele with P-glycoprotein expression and activity in vivo Proc Natl Acad Sci USA 97 2000 3473
31. E. Lechapt-Zalcman, I. Hurbain, and R. Lacave MDR1-Pgp 170 expression in human bronchus Eur Respir J 10 1997 1837
32. M. van der Deen, W. Timens, and H. Timmer-Bosscha Reduced inflammatory response in cigarette smoke exposed Mrp1/Mdr1a/1b deficient mice Respir Res 8 2007 49
33. H. Wang, G. Jin, and H. Wang Genetic susceptibility of lung cancer associated with common variants in the 3' untranslated regions of the adenosine triphosphate-binding cassette B1 (ABCB1) and ABCC1 candidate transporter genes for carcinogen export Cancer 115 2009 595
34. J.J. Grau, M. Caballero, and M. Campayo Gene single nucleotide polymorphism accumulation improves survival in advanced head and neck cancer patients treated with weekly paclitaxel Laryngoscope 119 2009 1484
35. D. Dai, D.C. Zeldin, and J.A. Blaisdell Polymorphisms in human CYP2C8 decrease metabolism of the anticancer drug paclitaxel and arachidonic acid Pharmacogenetics 11 2001 597
36. K. Golka, V. Prior, and M. Blaszkewicz The enhanced bladder cancer susceptibility of NAT2 slow acetylators towards aromatic amines: A review considering ethnic differences Toxicol Lett 128 2002 229
37. C. Bouchardy, K. Mitrunen, and H. Wikman N-acetyltransferase NAT1 and NAT2 genotypes and lung cancer risk Pharmacogenetics 8 1998 291
38. G.R. Simon, S. Sharma, and A. Cantor ERCC1 expression is a predictor of survival in resected patients with non-small cell lung cancer Chest 127 2005 978
39. K.A. Olaussen, A. Dunant, and P. Fouret DNA repair by ERCC1 in non-small-cell lung cancer and cisplatin-based adjuvant chemotherapy N Engl J Med 355 2006 983
40. E.C. Friedberg How nucleotide excision repair protects against cancer Nat Rev Cancer 1 2001 223
41. J. Yin, U. Vogel, and L. Guo Lack of association between DNA repair gene ERCC1 polymorphism and risk of lung cancer in a Chinese population Cancer Genet Cytogenet 164 2006 66
42. D. Isla, C. Sarries, and R. Rosell Single nucleotide polymorphisms and outcome in docetaxel-cisplatin-treated advanced non-small-cell lung cancer Ann Oncol 15 2004 1194
43. J.H. Pan, J.X. Han, and J.M. Wu CYP450 polymorphisms predict clinic outcomes to vinorelbine-based chemotherapy in patients with non-small-cell lung cancer Acta Oncol 46 2007 361
44. N. Viñolas, M. Provencio, and N. Reguart Single nucleotide polymorphisms in MDR1 gene correlates with outcome in advanced non-small-cell lung cancer patients treated with cisplatin plus vinorelbine Lung Cancer 71 2011 191
45. A. Potti, S. Mukherjee, and R. Petersen A genomic strategy to refine prognosis in early-stage non-small-cell lung cancer N Engl J Med 355 2006 570